Workshop: Phosphatidylethanol: The "Hemoglobin A1c" for Alcohol Use Disorder?-Phosphatidylethanol: The "Hemoglobin A1c" for Alcohol Use Disorder?

Phosphatidylethanol: The "Hemoglobin A1c" for Alcohol Use Disorder?

Video Transcription

Video Summary

The video transcript discusses the use of phosphatidylethanol (PEth) as a biomarker for alcohol use disorder. The speakers, who are psychiatrists, discuss the potential benefits and challenges of using PEth in various clinical settings, including screening, diagnosis, monitoring, and supporting recovery. They emphasize the importance of effective communication when discussing PEth results with patients, as well as the need to understand the technical aspects of PEth testing and how it relates to other alcohol biomarkers. The speakers also highlight the potential for PEth to provide valuable information in cases where patients may not accurately report their alcohol use. Overall, the speakers believe that PEth monitoring has the potential to be a game changer in the field of addiction psychiatry and should be considered in appropriate clinical situations.

Keywords

phosphatidylethanol

PEth

biomarker

alcohol use disorder

clinical settings

screening

diagnosis

monitoring

recovery

communication

	The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.		400 Massasoit Avenue Suite 108 East Providence, RI 02914 cmecpd@aaap.org Privacy	About Advocacy Membership Fellowship Education and Resources Training Events